ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
出版年份 2019 全文链接
标题
ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-14
DOI
10.1186/s13195-019-0497-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HDL and ASCVD Risk Stratification – A Debate
- (2019) Philip Barter et al. ATHEROSCLEROSIS
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- HDL and cardiovascular disease
- (2019) Stephen J. Nicholls et al. PATHOLOGY
- Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer’s Disease? A Systematic Review and Meta-Analysis
- (2018) Susanna C. Larsson et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s Disease: Advances in Drug Development
- (2018) Morgane Piton et al. JOURNAL OF ALZHEIMERS DISEASE
- Circulating HDL levels control hypothalamic astrogliosis via ApoA-I
- (2018) Anna Goetz et al. JOURNAL OF LIPID RESEARCH
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Apolipoprotein C-III is an Amyloid-β-Binding Protein and an Early Marker for Alzheimer's Disease
- (2018) Yao-Hsiang Shih et al. JOURNAL OF ALZHEIMERS DISEASE
- Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study
- (2018) Zachary A. Marcum et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults
- (2018) Nicole M. Armstrong et al. NEUROBIOLOGY OF AGING
- The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
- (2017) Gargi Banerjee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture
- (2017) Jérôme Robert et al. Molecular Neurodegeneration
- Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease
- (2017) Sofía Fernández-de Retana et al. NEUROBIOLOGY OF AGING
- Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice
- (2016) Jérôme Robert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model
- (2016) Peng Yang et al. EXPERIMENTAL NEUROLOGY
- Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women
- (2016) Kristyn A. Bates et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Sex differences in Alzheimer's disease and other dementias
- (2016) Carolyn M Mazure et al. LANCET NEUROLOGY
- Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study
- (2016) Zoe Arvanitakis et al. LANCET NEUROLOGY
- Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood–Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery
- (2016) Qingxiang Song et al. MOLECULAR PHARMACEUTICS
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
- (2015) Yang Xiang et al. ACTA NEUROPATHOLOGICA
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial
- (2015) Stephen J. Nicholls et al. American Journal of Cardiovascular Drugs
- Opposing effects ofApoe/Apoa1double deletion on amyloid-β pathology and cognitive performance in APP mice
- (2015) Nicholas F. Fitz et al. BRAIN
- ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy
- (2015) Alex Montañola et al. NEUROMOLECULAR MEDICINE
- Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta
- (2014) Qingxiang Song et al. ACS Nano
- The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
- (2014) Johannes Attems et al. BMC Medicine
- Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
- (2014) J.-C. Tardif et al. EUROPEAN HEART JOURNAL
- HDL-targeted therapies: progress, failures and future
- (2014) Bronwyn A. Kingwell et al. NATURE REVIEWS DRUG DISCOVERY
- Aging affects high-density lipoprotein composition and function
- (2013) Michael Holzer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
- (2013) Bruce Reed et al. JAMA Neurology
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenarians
- (2011) Francesc Formiga et al. Geriatrics & Gerontology International
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
- (2011) Christian Besler et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease
- (2011) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Baseline Serum Cholesterol Is Selectively Associated With Motor Speed and Not Rates of Cognitive Decline: The Women's Health and Aging Study II
- (2011) M. M. Mielke et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease
- (2010) Christiane Reitz et al. ARCHIVES OF NEUROLOGY
- Recombinant High-Density Lipoprotein Formulations
- (2010) Esad Vucic et al. Current Atherosclerosis Reports
- Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
- (2010) Iliya Lefterov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
- (2010) Terry L. Lewis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function
- (2010) Catherine E. Watson et al. JOURNAL OF LIPID RESEARCH
- A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
- (2010) Ron Waksman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
- (2009) Sajoscha A. Sorrentino et al. CIRCULATION
- Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease
- (2009) Shaila P. Handattu et al. NEUROBIOLOGY OF DISEASE
- Intracerebroventricular amyloid- antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice
- (2009) D. R. Thakker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- (2008) LeAnne T. Bloedon et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started